Moderna, Inc. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Moderna, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q1 2025.
- Moderna, Inc. Operating Income (Loss) for the quarter ending March 31, 2025 was -$1.05B, a 17.1% increase year-over-year.
- Moderna, Inc. Operating Income (Loss) for the twelve months ending March 31, 2025 was -$3.73B, a 27.4% increase year-over-year.
- Moderna, Inc. annual Operating Income (Loss) for 2024 was -$3.95B, a 6.94% increase from 2023.
- Moderna, Inc. annual Operating Income (Loss) for 2023 was -$4.24B, a 145% decline from 2022.
- Moderna, Inc. annual Operating Income (Loss) for 2022 was $9.42B, a 29.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)